Genetic diversity of Plasmodium falciparum and distribution of drug resistance haplotypes in Yemen

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Al Hamidhi, Salama ^a   Mahdy, Mohammed Ak ^b,c   Al Hashami, Zainab ^a   Al Farsi, Hissa ^a   Al Mekhlafi, Abdulsalam M ^c   Idris, Mohamed A ^a   Beja Pereira, Albano ^d   Babiker, Hamza A ^a,e  

^a SULTAN QABOOS UNIVERSITY   (Oman)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c SANA A UNIVERSITY   (Yemen)

^d CENTRO DE INVESTIGAÇÃO EM BIODIVERSIDADE E RECURSOS GENÉTICOS   (Portugal)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Arabian Peninsula; Drug resistance; Genetic diversity; Malaria; Plasmodium falciparum; Yemen

Indexed keywords

CHLOROQUINE; PYRIMETHAMINE; SULFADOXINE; ANTIMALARIAL AGENT;

ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CHROMOSOME 8; GENE FLOW; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MALARIA FALCIPARUM; NONHUMAN; PLASMODIUM FALCIPARUM; PREVALENCE; YEMEN; CROSS-SECTIONAL STUDY; DRUG EFFECTS; DRUG RESISTANCE; GENETICS; MALARIA, FALCIPARUM; PARASITOLOGY;

ANTIMALARIALS; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE; GENETIC VARIATION; HAPLOTYPES; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PREVALENCE; YEMEN;

EID: 84880110439     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-244     Document Type: Article

References (64)

1. Antimalarial drug resistance in the Eastern Mediterranean region. Abdel-Hameed AA, Eastern Mediterranean Health 2003 9 492 508 (Pubitemid 40485288)
2. High frequency of Plasmodium falciparum chloroquine resistance marker (Pfcrt T76 mutation) in Yemen: an urgent need to re-examine malaria drug policy. Al-Mekhlafi AM, Mahdy MA, Al-Mekhlafi HM, Azazy AA, Fong MY, Parasit Vectors 2011 4 94 10.1186/1756-3305-4-94 21619624
3. Analysis of gene mutations involved in chloroquine resistance in Plasmodium falciparum parasites isolated from patients in the southwest of Saudi Arabia. Bin Dajem SM, Al-Qahtani A, Ann Saudi Med 2010 30 187 192 10.4103/0256-4947.62826 20427933
4. Status of Malaria in the Kingdom of Bahrain: a 10-year Review. Ismaeel AY, Senok AC, Jassim Al-Khaja KA, Botta GA, J Travel Med 2004 11 97 101 15109474 (Pubitemid 38523683)
5. Soucy A, Mixed migration from the Horn of Africa to Yemen Kenya: Protection risks and challenges 2011
6. WHO, World malaria report 2012 Geneva: World Health Organization 2011
7. Chloroquine-resistant Plasmodium falciparum local strain in Taiz Governorate, Republic of Yemen. Alkadi HO, Al-Maktari MT, Nooman MA, Chemotherapy 2006 52 166 170 10.1159/000093592 16720983 (Pubitemid 43882413)
8. Mamser A, Report on a visit to the Yemen Arab Republic from 14-2 to 13-3-1989 Geneva, EMRO: World Health Organization WHO/RA/MAL/005. 1989 1 5
9. The prevalence and degree of resistance of Plasmodium falciparum to first-line antimalarial drugs: an in vitro study from a malaria endemic region in Yemen. Al-Shamahy H, Al-Harazy AH, Harmal NS, Al-Kabsi AM, Ann Saudi Med 2007 27 432 436 10.4103/0256-4947.51457 18059124 (Pubitemid 351234119)
10. Molecular markers of anti-malarial drug resistance in Lahj Governorate, Yemen: baseline data and implications. Mubjer R, Adeel A, Chance M, Hassan A, Malar J 2011 10 245 10.1186/1475-2875-10-245 21854642
11. WHO, World malaria report 2012 Geneva: World Health Organization 2012
12. Genotyping of Plasmodium falciparum gametocytes by reverse transcriptase polymerase chain reaction. Menegon M, Severini C, Sannella A, Paglia MG, Sangaré D, Abdel-Wahab A, Abdel-Muhsin A-MA, Babiker H, Walliker D, Alano P, Mol Biochem Parasitol 2000 111 153 161 10.1016/S0166-6851(00)00314-5 11087925
13. Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum field isolates from Myanmar. Kang J, Moon S, Kim J, Cho S, Lin K, Sohn W, Kim T, Na B, Malar J 2010 9 131 10.1186/1475-2875-9-131 20478015
14. Polymorphism in two merozoite surface proteins of Plasmodium falciparum isolates from Gabon. Aubouy A, Migot-Nabias F, Deloron P, Malar J 2003 2 12 10.1186/1475-2875-2-12 12773207
15. Intercontinental spread of pyrimethamine-resistant malaria. Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T, Science 2004 305 1124 1124 10.1126/science.1098876 15326348 (Pubitemid 39100317)
16. Local differentiation in Plasmodium falciparum drug resistance genes in Sudan. Abdel-Muhsin AA, Mackinnon MJ, Awadalla P, Ali E, Suleiman S, Ahmed S, Walliker D, Babiker HA, Parasitology 2003 126 391 400 10.1017/S0031182003003020 12793642 (Pubitemid 36649293)
17. A molecular marker for chloroquine-resistant falciparum malaria. Djimdé A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourté Y, Dicko A, Su XZ, Nomura T, Fidock A, Wellems TE, Plowe CV, N Engl J Med 2001 344 257 263 10.1056/NEJM200101253440403 11172152 (Pubitemid 32108530)
18. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. Plowe CV, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley PA, Franco JGE, Mollinedo RE, Avila JC, Cespedes JL, Carter D, Doumbo OK, J Infect Dis 1997 176 1590 1596 10.1086/514159 9395372 (Pubitemid 27518161)
19. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE, AmJTrop Med Hyg 1995 52 565 568
20. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LMB, bir Singh Sidhu A, Naudé B, Deitsch KW, Su XZ, Wootton JC, Roepe PD, Wellems TE, Mol Cell 2000 6 861 871 10.1016/S1097-2765(05)00077-8 11090624
21. Chemotherapy and drug resistance in malaria. Cowman AF, Foote SJ, Int J Parasitol 1990 20 503 513 10.1016/0020-7519(90)90198-V 2210944 (Pubitemid 20273987)
22. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Cowman AF, Morry MJ, Biggs BA, Cross GA, Foote SJ, Proc Natl Acad Sci USA 1988 85 9109 9113 10.1073/pnas.85.23.9109 3057499 (Pubitemid 19001849)
23. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization. Wang P, Read M, Sims PFG, Hyde JE, Mol Microbiol 1997 23 979 986 10.1046/j.1365-2958.1997.2821646.x 9076734 (Pubitemid 27096733)
24. Molecular evolutionary genetics. Nei M, Am J Physical Anthropology 1988 75 428 429 10.1002/ajpa.1330750317
25. Estimation of numbers of malaria clones in blood samples. Hill WG, Babiker HA, Proc R Soc London Series B-Biol Sci 1995 262 249 257 10.1098/rspb.1995.0203 (Pubitemid 26023703)
26. Testing heterozygote excess and deficiency. Rousset F, Raymond M, Genetics 1995 140 1413 1419 7498780
27. Covariances of relatives stemming from a population undergoing mixed self and random mating. Cockerham CC, Weir BS, Biometrics 1984 40 157 164 10.2307/2530754 6733226 (Pubitemid 15277600)
28. GenAlEx 6.5: genetic analysis in Excel. Population genetic software for teaching and research-an update. Peakall R, Smouse PE, Bioinformatics 2012 28 2537 2539 10.1093/bioinformatics/bts460 22820204
29. Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. Anderson TJC, Haubold B, Williams JT, Estrada-Franco JG, Richardson L, Mollinedo R, Bockarie M, Mokili J, Mharakurwa S, French N, Whitworth J, Velez ID, Brockman AH, Nosten F, Ferreira MU, Day KP, Mol Biol Evol 2000 17 1467 1482 10.1093/oxfordjournals.molbev.a026247 11018154
30. Population genetic structure of Plasmodium falciparum across a region of diverse endemicity in West Africa. Mobegi VA, Loua KM, Ahouidi AD, Satoguina J, Nwakanma DC, Amambua-Ngwa A, Conway DJ, Malar J 2012 11 223 10.1186/1475-2875- 11-223 22759447
31. The question of Plasmodium falciparum population structure. Awadalla P, Walliker D, Babiker H, Mackinnon M, Trends Parasitol 2001 17 351 353 10.1016/S1471-4922(01)02034-7 11685887 (Pubitemid 33042442)
32. Drug resistance and genetic mapping in Plasmodium falciparum<. Hayton K, Su XZ, Curr Genet 2008 54 223 239 10.1007/s00294-008-0214-x 18802698
33. A large Plasmodium vivax reservoir and little population structure in the South Pacific. Koepfli C, Timinao L, Antao T, Barry AE, Siba P, Mueller I, Felger I, PLoS One 2013 8 66041 10.1371/journal.pone.0066041 23823758
34. Imported malaria in United Arab Emirates: Evaluation of a new DNA extraction technique using nested PCR. Sultan DM, Khalil MM, Abdouh AS, Doleh WF, Al Muthanna AAM, Korean J Parasitol 2009 47 227 233 10.3347/kjp.2009.47.3. 227 19724695
35. Detection of drug resistance markers for chloroquine and pyrimethamine-sulfadoxine in Jazan area, Saudi Arabia using PCR and restriction digestion. Al Harthi SA, J Egypt Soc Parasitol 2007 37 17 30 17580565
36. Impact of genetic complexity on longevity and gametocytogenesis of Plasmodium falciparum during the dry and transmission-free season of eastern Sudan. Nassir E, Abdel-Muhsin AMA, Suliaman S, Kenyon F, Kheir A, Geha H, Ferguson HM, Walliker D, Babiker HA, Int J Parasitol 2005 35 49 55 10.1016/j.ijpara.2004.10.014 15619515 (Pubitemid 41556671)
37. High gametocyte complexity and mosquito infectivity of Plasmodium falciparum in the Gambia. Nwakanma D, Kheir A, Sowa M, Dunyo S, Jawara M, Pinder M, Milligan P, Walliker D, Babiker HA, Int J Parasitol 2008 38 219 227 10.1016/j.ijpara.2007.07.003 17709108 (Pubitemid 350266643)
38. Clinical situation of endemic malaria in Yemen. Al-Mekhlafi AMQ, Mahdy MAK, Azazy AA, Fong MY, Trop Biomed 2010 27 551 558 21399597
39. Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of Pfmdr1-86F in natural parasite isolates. Dlamini SV, Beshir K, Sutherland CJ, Malar J 2010 9 68 10.1186/1475-2875-9-68 20199676
40. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan. Al-Saai S, Kheir A, Abdel-Muhsin AMA, Al-Ghazali A, Nwakanma D, Swedberg G, Babiker HA, Infect Genet Evol 2009 9 778 783 10.1016/j.meegid.2009. 04.010 19379843
41. Genetic backgrounds of the Plasmodium falciparum chloroquine resistant transporter (Pfcrt) alleles in Pakistan. Rawasia WF, Sridaran S, Patel JC, Abdallah J, Ghanchi NK, Barnwell JW, Escalante AA, Udhayakumar V, Beg MA, Infect Genet Evol 2012 12 278 281 10.1016/j.meegid.2011.11.008 22138496
42. Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan. Ghanchi NK, Ursing J, Beg MA, Veiga MI, Jafri S, Mårtensson A, Malar J 2011 10 18 10.1186/1475-2875-10- 18 21272384
43. Association of Pfcrt but not Pfmdr1 alleles with chloroquine resistance in Iranian isolates of Plasmodium falciparum. Zakeri S, Afsharpad M, Kazemzadeh T, Mehdizadeh K, Shabani A, Djadid ND, Am J TropMed Hyg 2008 78 633 640 (Pubitemid 351845169)
44. Detection of K76T mutation inPfcrt gene as an applicable genetic marker for prediction of chloroquine resistant falciparum malaria in isolates from an endemic district of Iran. Esmaeili Rastaghi AR, Nateghpour M, Assmar M, Razavi MR, Kanbara H, Uemura H, Naddaf SR, Keshavarz H, Raeisi A, Mohebali M, Iran J Parasitol 2008 3 48 56
45. High prevalence of the 437G mutation associated with sulfadoxine resistance among Plasmodium falciparum clinical isolates from Iran, three years after the introduction of sulfadoxine-pyrimethamine. Zakeri S, Farahani MS, Afsharpad M, Salehi M, Raeisi A, Djadid ND, Int J Infect Dis 2010 14 123 e128 20399698
46. Molecular survey of Plasmodium falciparum resistance in south-eastern Iran. Jafari S, Le Bras J, Asmar M, Durand R, Ann Trop Med Parasitol 2003 97 119 124 10.1179/000349803235001552 12803866 (Pubitemid 36543232)
47. Pfcrt haplotypes and the evolutionary history of chloroquine-resistant Plasmodium falciparum. Awasthi G, Satya GBK, Das A, Mem Inst Oswaldo Cruz 2012 107 129 134 10.1590/S0074-02762012000100018 22310546
48. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, Magill AJ, Su XZ, Nature 2002 418 320 323 10.1038/nature00813 12124623 (Pubitemid 34790681)
49. Pfcrt haplotypes and in-vivo chloroquine response in Sundergarh district, Orissa, India. Pati SS, Mishra S, Mohanty S, Mohapatra DN, Sahu PK, Priyadarshi N, Kumar S, Sharma SK, Tyagi PK, Chitnis CE, Das BS, Trans R Soc Trop Med Hyg 2007 101 650 654 10.1016/j.trstmh.2007.01.008 17428514 (Pubitemid 46722239)
50. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Reed MB, Sallba KJ, Caruana SR, Kirk K, Cowman AF, Nature 2000 403 906 909 10.1038/35002615 10706290 (Pubitemid 30130994)
51. Selection of Pfmdr1 and Pfcrt alleles in amodiaquine treatment failure in north-western Burkina Faso. Danquah I, Coulibaly B, Meissner P, Petruschke I, Müller O, Mockenhaupt FP, Acta Trop 2010 114 63 66 10.1016/j.actatropica. 2009.12.008 20060374
52. The role of Pfmdr1 in Plasmodium falciparum tolerance to artemether-lumefantrine in Africa. Sisowath C, Ferreira PE, Bustamante LY, Dahlström S, Mårtensson A, Björkman A, Krishna S, Gil JP, Trop Med Int Health 2007 12 736 742 10.1111/j.1365-3156.2007.01843.x 17550470 (Pubitemid 46872790)
53. Decreased prevalence of Plasmodium falciparum resistance markers to amodiaquine despite its wide scale use as ACT partner drug in Zanzibar. Fröberg G, Jörnhagen L, Morris U, Shakely D, Msellem M, Gil J, Björkman A, Mårtensson A, Malar J 2012 11 321 10.1186/1475-2875-11- 321 22966778
54. Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with Pfmdr1 polymorphisms. Malmberg M, Ferreira PE, Tarning J, Ursing J, Ngasala B, Björkman A, Mårtensson A, Gil JP, J Infect Dis 2013 207 842 847 10.1093/infdis/jis747 23225895
55. Availability and prescription practice of anti-malaria drugs in the private health sector in Yemen. Bin Ghouth AS, J Infect Dev Ctries 2013 7 404 412 23669430
56. The dihydrofolate reductase-thymidylate synthetase gene in the drug resistance of malaria parasites. Hyde JE, Pharmacol Ther 1990 48 45 59 10.1016/0163-7258(90)90017-V 2274577 (Pubitemid 20322217)
57. Stepwise acquisition of pyrimethamine resistance in the malaria parasite. Lozovsky ER, Chookajorn T, Brown KM, Imwong M, Shaw PJ, Kamchonwongpaisan S, Neafsey DE, Weinreich DM, Hartl DL, Proc Natl Acad Sci USA 2009 106 12025 12030 10.1073/pnas.0905922106 19587242
58. The evolutionary landscape of antifolate resistance in Plasmodium falciparum. Costanzo MS, Hartl DL, J Genetics 2011 90 187 190 10.1007/s12041-011-0072-z
59. Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of Northern Tanzania. Pearce RJ, Drakeley C, Chandramohan D, Mosha F, Roper C, Antimicrob Agents Chemother 2003 47 1347 1354 10.1128/AAC.47.4.1347- 1354.2003 12654669 (Pubitemid 36368596)
60. Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran. Afsharpad M, Zakeri S, Pirahmadi S, Djadid ND, Acta Trop 2012 121 13 18 10.1016/j.actatropica.2011.09.010 22001304
61. Prevalence of antimalarial drug resistance mutations in Plasmodium vivax and P. falciparum from a malaria-endemic area of Pakistan. Khatoon L, Baliraine FN, Bonizzoni M, Malik SA, Yan G, Am J TropMed Hyg 2009 81 525 528
62. Frequency distribution of antimalarial drug resistance alleles among Plasmodium falciparum isolates from Gezira State, Central Sudan, and Gedarif State, Eastern Sudan. Menegon M, Talha AA, Severini C, Elbushra SM, Mohamedani AA, Malik EM, Mohamed TA, Wernsdorfer WH, Majori G, Nour BYM, Am J TropMed Hyg 2010 83 250 257
63. Different mutation patterns of Plasmodium falciparum among patients in Jimma University Hospital, Ethiopia. Eshetu T, Berens-Riha N, Fekadu S, Tadesse Z, Gürkov R, Hölscher M, Löscher T, Miranda IB, Malar J 2010 9 226 10.1186/1475-2875-9-226 20691106
64. Molecular surveillance of drug resistance through imported isolates of Plasmodium falciparum in Europe. Jelinek T, Peyerl-Hoffmann G, Mühlberger N, Wichmann O, Wilhelm M, Schmider N, Grobusch MP, von Sonnenburg F, Gascon J, Laferl H, Hatz C, Alifrangis M, Burchard G, McWhinney P, Schulze M, Kollaritsch H, da Cunha S, Beran J, Kern P, Gjørup I, Cuadros J, Malar J 2002 1 11 10.1186/1475-2875-1-11 12423552